- Home
- GCV vs BYSI Comparison
GCV vs BYSI Comparison
Compare GCV & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- BYSI
- Stock Information
- Founded
- GCV 1988
- BYSI 2010
- Country
- GCV United States
- BYSI United States
- Employees
- GCV N/A
- BYSI N/A
- Industry
- GCV Finance/Investors Services
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- GCV Finance
- BYSI Health Care
- Exchange
- GCV Nasdaq
- BYSI Nasdaq
- Market Cap
- GCV 84.3M
- BYSI 73.4M
- IPO Year
- GCV N/A
- BYSI 2017
- Fundamental
- Price
- GCV $4.25
- BYSI $1.78
- Analyst Decision
- GCV
- BYSI
- Analyst Count
- GCV 0
- BYSI 0
- Target Price
- GCV N/A
- BYSI N/A
- AVG Volume (30 Days)
- GCV 57.9K
- BYSI 34.8K
- Earning Date
- GCV 01-01-0001
- BYSI 11-11-2025
- Dividend Yield
- GCV 13.04%
- BYSI N/A
- EPS Growth
- GCV N/A
- BYSI N/A
- EPS
- GCV N/A
- BYSI N/A
- Revenue
- GCV N/A
- BYSI N/A
- Revenue This Year
- GCV N/A
- BYSI N/A
- Revenue Next Year
- GCV N/A
- BYSI N/A
- P/E Ratio
- GCV N/A
- BYSI N/A
- Revenue Growth
- GCV N/A
- BYSI N/A
- 52 Week Low
- GCV $3.15
- BYSI $0.98
- 52 Week High
- GCV $4.58
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- GCV 64.07
- BYSI 50.26
- Support Level
- GCV $4.00
- BYSI $1.72
- Resistance Level
- GCV $4.22
- BYSI $1.85
- Average True Range (ATR)
- GCV 0.07
- BYSI 0.10
- MACD
- GCV 0.01
- BYSI 0.01
- Stochastic Oscillator
- GCV 89.81
- BYSI 59.00
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.